ADRs Advance; Connect Biopharma Holdings Climbs 19%
This article was automatically generated by MarketWatch using technology from Automated Insights.
International stocks trading in New York closed higher on Friday, as the S&P/BNY Mellon index of American depositary receipts rose 0.1% to 183.93.
The European index dropped 0.3% to 178.52. The Asian index added 0.7% to 219.12. The Latin American index declined 0.4% to 189.48, while the emerging-markets index added 0.3% to 353.54.
China's Connect Biopharma Holdings was the biggest leader during the session, jumped 19% to $1.52, and China-based Concord Medical Services Holdings surged 15% to 95 cents. Fangdd Network Group, which is based in China, rounded out the top three leaders on Friday, with shares that increased 8.9% to 59 cents.
NaaS Technology, based in China, posted the largest decline, tumbled 16% to $2.43, followed by shares of China's Adlai Nortye, which declined 12% to $3.26. Shares of United Kingdom-based Renalytix lost 11% to 23 cents.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 28, 2024 17:05 ET (21:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
13 Charts On the Market’s Q2 Turnaround
-
10 Top-Performing Dividend Stocks of Q2 2024
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations
-
Real Estate: Interest Rate Movements Drive Performance
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities